Stories

Quitting smoking significantly boosts recovery from substance use disorders (SUDs), with odds rising up to 42 times. The importance of addressing smoking in addiction treatment is emphasized by experts like Dr. Volkow and Dr. Compton. Historical views linking quitting smoking with hindering recovery are debunked by studies showing no negative impact on SUD outcomes. Treatments like nicotine replacement therapy and medications are recommended. Vaping's role in SUD recovery is uncertain but reducing nicotine intake is advised. Smoking cessation, including vaping, is crucial for SUD patients' health and healing, as all addictive substances impact recovery pathways in the brain. Prioritizing smoking cessation in addiction treatment is vital for positive outcomes.

A recent study in The Lancet reveals a rise in e-cigarette use among Irish people, particularly the youth, without a strong link to quitting smoking. Although some evidence suggests that e-cigarettes may assist in smoking cessation, concerns about health risks and a new generation getting hooked on nicotine are growing. The research calls for urgent action to curb vaping, especially among young people. Despite declining smoking rates in Ireland, the use of nicotine products, including e-cigarettes, has surged. The study, based on data from the Healthy Ireland survey, warns of a significant public health issue and emphasizes the need for stricter regulations on vaping.

Texas now prohibits the marketing and sale of most disposable e-cigarette products, including THC vapes, under Senate Bill 2024, effective from Sept. 1. The law targets products designed to appeal to minors and those produced in certain countries. Despite concerns about impacting businesses like The Glassmith, some individuals like Andrés Valdez rely on THC and vapes for medical reasons. Critics, including Tyler Varisco, question the ban's effectiveness in managing substance use. Meanwhile, students like Matthew Handojo highlight the potential risks of obtaining vapes from unregulated sources.

Sesh, a newcomer in the nicotine product market, aims to challenge established brands like Zyn by offering safer white pouches. Backed by celebrities and $40 million in funding, Sesh's unique formula sets it apart. While still addictive, pouches are seen as a less harmful alternative to cigarettes and vapes. Despite concerns about attracting new users, Sesh focuses on responsible marketing and growth. With FDA approval and growing popularity, Sesh strives to redefine nicotine consumption and compete with Big Tobacco. The company's success reflects a shift towards safer nicotine products and away from traditional smoking methods.

Denver's ban on flavored tobacco products, signed by Mayor Mike Johnston, targets vapes, e-cigarettes, and menthol cigarettes, with full enforcement set for January 1, 2026. Supporters argue these products are marketed to youth and minority communities. A coalition is pushing to repeal the ban, collecting over 17,000 signatures. Proponents, such as health organizations, formed Denver Kids vs Big Tobacco to promote the ban. Critics, led by the Rocky Mountain Smoke Free Alliance, advocate for stricter regulations instead. The ban's fate will be determined by voters this November, shaping Denver's stance against the tobacco industry. The move follows a vetoed 2021 ban and aligns Denver with other Colorado cities combatting flavored tobacco.

Nicotine and alcohol activate a brain circuit connecting reward and anxiety by triggering an inhibitory feedback loop between dopaminergic neurons. This mechanism explains why these substances reinforce consumption behavior while inducing anxiety. Researchers used optogenetics to block this loop and prevent anxious behavior. The study sheds light on the link between reward and negative emotions, providing insights into addiction and co-use of tobacco and alcohol.

A study observed pregnant smokers using very low-nicotine cigarettes (VLNC), sparking debate over reducing harms. Published in Preventative Medicine, it aimed to explore effects on smoking during pregnancy. Yet, critics argue VLNCs may not decrease smoking and could be as harmful. The FDA proposed reducing nicotine in tobacco, claiming it could prevent deaths. However, opponents question its efficacy and advocate for safer alternatives like vaping. The study found VLNCs didn’t reduce smoking in pregnant women but also didn't lead to more smoking. Researchers defended the study's ethical standards, stating it was not a smoking-cessation trial but part of a national policy investigation. Critics, like Dr. Michael Siegel, demand retraction, citing ethical violations.

The City of Baltimore is suing Philip Morris and Swedish Match for allegedly targeting youth with Zyn nicotine pouches through flavors, social media, rewards programs, and marketing them as tobacco-free. The complaint lacks solid evidence and makes questionable claims, such as linking adult products to youth targeting. The lawsuit is criticized for misconstruing basic marketing strategies and lacking substantial proof of deliberate youth targeting. The City seeks fines and remedies despite weak arguments, suggesting a lack of substance in the case. The lawsuit is seen as a frivolous attempt based on weak reasoning and misconceptions about marketing tactics.

Teenagers are obtaining e-cigarettes from the black market, increasing addiction risks despite a study linking vaping to strokes. A survey found that most underage vapers get their devices online, with concerns raised about weak age verification methods in shops. The growth of this unregulated market poses dangers to youth health. Research has shown vaping's association with various health risks, with experts urging stricter age checks and regulation. Despite e-cigarettes being promoted for smoking cessation, there are worries about non-smoking youths taking up vaping. Enhancing age verification measures and regulation are crucial to combat youth vaping and its potential health harms.

Dutch doctors have filed a complaint against Snapchat's parent company, Snap, for not preventing illegal vape sales to teenagers in the Netherlands. The complaint alleges that Snapchat violates the EU's Digital Services Act by allowing dealers to use the app for selling nicotine products. Despite promised safeguards, investigations show teenagers can still access vape dealers on the platform easily. Doctors argue that Snap's measures have failed, leading to a vape epidemic among young people. The doctors urge regulators to take stronger action to protect minors from online risks. Snapchat has responded by enhancing safeguards, but concerns persist about the platform's role in youth nicotine addiction.